Sign in

CIK 0000012239 · Non-accelerated filer<br>Smaller reporting company

Dominari Holdings Inc.

Sign in to watch
Ticker
DOMH
Exchange
Nasdaq
Industry
Security Brokers, Dealers & Flotation Companies
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520849320
Phone
(212) 393-4540
Business address
725 FIFTH AVENUE, 22ND FLOOR, NEW YORK, NY, 10022
Former names
Aikido Pharma Inc., AIkido Pharma Inc., SPHERIX INC, BIOSPHERICS INC
  1. 4 Open-market buy COO bought 1,000 shares at $2.26 ($2,259)
  2. 4 Open-market buy Director bought 1,000 shares at $2.20 ($2,200)
  3. 4 Open-market buy CEO bought 2,804 shares at an average $2.13 ($5,965)
  4. 4 Open-market buy Director bought 2,000 shares at $2.05 ($4,103)
  5. 4 Open-market buy CEO bought 2,500 shares at $1.97 ($4,916)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy CEO bought 2,500 shares at $1.93 ($4,825)
  8. 4 Grant or award Chief Financial Officer acquired 96,311 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 15,000 shares at an average $2.62 ($39,271)
  11. 4 Open-market buy CEO bought 15,000 shares at an average $2.59 ($38,899)
  12. 4 Open-market buy Director bought 2,000 shares at $2.55 ($5,091)
  13. 4 Open-market buy Director bought 2,000 shares at $2.74 ($5,471)
  14. 4 Open-market buy CEO bought 2,000 shares at $2.75 ($5,494)
  15. 4 Open-market buy Director bought 2,000 shares at $2.82 ($5,631)
  16. 4 Open-market buy Director bought 2,000 shares at $2.90 ($5,794)
  17. 4 Open-market buy CEO bought 2,000 shares at $2.86 ($5,718)
  18. 4 Open-market buy Director bought 2,369 shares at an average $2.97 ($7,028)
  19. 4 Open-market buy CEO bought 2,000 shares at $2.94 ($5,880)
  20. 4 Open-market buy Director bought 2,000 shares at $3.00 ($6,000)

Page 4 of 17 · 335 filings